Morphosys shares fall after dermatitis treatment flops

German biotech company Morphosys halted development of an experimental atopic dermatitis treatment that analysts had pinned hopes of blockbuster sales potential on, sending its shares down as much as 6.8% on Tuesday.

from Reuters: Health News https://ift.tt/2q6cr3V
via IFTTT